John Sahl Andersen

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

Medicine, Oncology, Pharmacotherapy +16

The Danish National Health Service Register

John Sahl Andersen, Niels de Fine Olivarius, Allan Krasnik · Scandinavian Journal of Public Health · 2011 · 910 citations

Health Professions, Health Services Administration, Clinical Medicine +11

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

Mace L. Rothenberg, Malcolm J. Moore, M. Christine Cripps et al. · Annals of Oncology · 1996 · 569 citations · Full text

Medicine, Oncology, Pharmacology +9

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 2023 · 169 citations

Medicine, Oncology, Pharmacology +10

A Case Study of an Adaptive Clinical Trial in the Treatment of Out-Patients with Depressive Disorder

Roy Tamura, Douglas E. Faries, John Sahl Andersen et al. · Journal of the American Statistical Association · 1994 · 148 citations

Public Health, Biostatistics, Psychiatry +17